Skip to main content
SpringerLink
Log in

Acute Heart Failure in the Setting of Acute Coronary Syndromes

  • Chapter
Acute Heart Failure

  • 2455 Accesses

Abstract

Acute heart failure in the setting of acute coronary syndromes (ACS) is a life-threatening situation that requires early identification and treatment. It may occur as the first manifestation of heart failure or in patients with previous heart disease, left ventricular dysfunction, and chronic symptoms of heart failure. In the majority of the patients, ischemic symptoms are clearly identified, but in others the symptoms may be subtle and the clinical picture is dominated by heart failure manifestations. Acute heart failure may present in several forms: forward failure (low output and cardiogenic shock), pulmonary congestion (including pulmonary edema), and right heart failure. Treatment should focus not only on improving the hemodynamics but also in the treatment of ischemia. A significant number of patients present left ventricular dysfunction with reduced left ventricular ejection fraction and only mild or transient symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Goldberg RJ, Samad NA, Yarzebski J, Gurtwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999;340:1162–1268.

    Article  CAS  PubMed  Google Scholar 

  2. Steg G, Dabbous OH, Feldman LJ, et al., for the GRACE Investigators. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: Observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 2004;109:494:499.

    Article  PubMed  Google Scholar 

  3. Brener SJ, Lincoff, A, Bates ER, for the GUSTO V Investigators. The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: Insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial. Am Heart J 2005;150:89–93.

    Article  PubMed  Google Scholar 

  4. Kashani A, Gibson M, Murphy SA, for the InTIME investigators. Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction. Am J Cardiol 2005;95:228.

    Article  PubMed  Google Scholar 

  5. Sutton MGJ, Norman Sharpe N. Left ventricular remodeling after myocardial infarction pathophysiology and therapy. Circulation 2000;101:2981.

    CAS  PubMed  Google Scholar 

  6. Mueller HS, Chatterjee K, Davis KB, et al. Present use of bedside right heart catheterization in patients with cardiac disease. ACC expert consensus document. J Am Coll Cardiol 1998;32:840–864.

    Article  CAS  PubMed  Google Scholar 

  7. Nieminen MN, Böhm M, Drexler H, et al. The Task Force on Acute Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of acute heart failure. Eur Heart J 2005;26:384–416.

    Article  PubMed  Google Scholar 

  8. Antman E, Amstrong PW, Bates ER, et al. ACC/AHA Guidelines for the Management of Patients UIT ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) Developed in Collaboration With the Canadian Cardiovascular Society. www.americanheart.org/.

    Google Scholar 

  9. Van de Werf F, Ardissino D, Betriu A, et al. For the task force on the management of acute myocardial infarction of the European Society of Cardiology Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2003;24:28–66.

    Article  PubMed  Google Scholar 

  10. Killip T, Kimball TJ. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967;20:457–464.

    Article  PubMed  Google Scholar 

  11. Forrester JS, Diamond G, Swan HJC. Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cardiol 1977;39:137.

    Article  CAS  PubMed  Google Scholar 

  12. Nohria A TS, Fang JC, Lewis EF, Jarcho JA, Mudge GH, Stevenson LW. Clinical Assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003;41:1797–1804.

    Article  PubMed  Google Scholar 

  13. Ross AM, Coyne KS, Moreyra E, et al., for the GUSTO-I. Angiographic Investigators. Extended mortality benefit of early postinfarction reperfusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial. Circulation 1998;97:1549–56.

    CAS  PubMed  Google Scholar 

  14. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002;39:591–597.

    Article  PubMed  Google Scholar 

  15. Hochman JS, Sleeper LA, White HD, et al., for the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Investigators. One-year survival following early revascularization for cardiogenic shock. JAMA 2001;285:190–192.

    Article  CAS  PubMed  Google Scholar 

  16. Amir Kashani A, Gibson M, Murphy S, et al., for the InTime investigators. Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction. Am J Cardiol 2005;95:228.

    Article  PubMed  Google Scholar 

  17. Gonçalves P de A, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005;26:865–872.

    Article  Google Scholar 

  18. Bussmann WD, Schupp D. Effects of sublingual nitroglycerin in emergency treatment of severe pulmonary oedema. Am J Cardiol 1978;41:931–936.

    Article  CAS  PubMed  Google Scholar 

  19. Cohn JN, Franciosa JA, GS Francis GS, et al. Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study. N Engl J Med 1982;306:1129–1135.

    Article  CAS  PubMed  Google Scholar 

  20. Leier CV. Positive inotropic therapy: An update and new agents. Curr Probl Cardiol 1996;21:521–581.

    Article  CAS  PubMed  Google Scholar 

  21. Thackray S, Easthaugh J, Freemantle N, et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a metaregression analysis. Eur J Heart Fail 2002;4:515–529.

    Article  CAS  PubMed  Google Scholar 

  22. Gheorghiade M, Gattis WA, Klein L. OPTIME in CHF trial: rethinking the use of inotropes in the management of worsening chronic heart failure resulting in hospitalization. Eur J Heart Fail 2003;5:9–12.

    Article  PubMed  Google Scholar 

  23. De Luca L, Colucci WS, Nieminen MS, Barry M. Massie BM, Gheorghiade M. Evidence-based use of levosimendan in different clinical settings. Eur Heart J 2006;27:1908–1920. www:eurheartj.oxfordjournals.org.

    Article  PubMed  CAS  Google Scholar 

  24. Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002;360:196–202.

    Article  CAS  PubMed  Google Scholar 

  25. Moiseyev VS, Poder P, Andrejevs N, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 2002;23(18):1422–1432.

    Article  CAS  PubMed  Google Scholar 

  26. Cody RJ. Clinical trials of diuretic therapy in heart failure: research directions and clinical considerations. J Am Coll Cardiol 1993;22(suppl A):165A–171A.

    CAS  PubMed  Google Scholar 

  27. Kelly CA, Newby DE, McDonagh TA et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrations. Eur Heart J 2002;23:1379–1386.

    Article  CAS  PubMed  Google Scholar 

  28. Masip J, Betbese AJ, Paez J et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial. Lancet 2000;356:2126–2132.

    Article  CAS  PubMed  Google Scholar 

  29. López-Sendón J, López de Sa E. Acute left ventricular failure. In: Sharpe N, ed. Heart failure 2000. London: Martin Dunitz, 1999:165–182.

    Google Scholar 

  30. Colucci W, Braunwald E. Pathophysiology of heart failure. In: Braunwald E, ed. Heart Disease. A Text book on Cardiovascular Medicine. Philadelphia: WB Saunders, 1997;394–420.

    Google Scholar 

  31. Levine RA. Dynamic mitral regurgitation. More than meets the eye. N Engl J Med 2004;351:1681–1684.

    Article  CAS  PubMed  Google Scholar 

  32. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000;102:2031–2037.

    CAS  PubMed  Google Scholar 

  33. López-Sendón J, Coma-Canella I, Gamallo C. Sensitivity and specificity of hemodynamic criteria in the diagnosis of acute right ventricular infarction. Circulation 1981;64:515–552.

    PubMed  Google Scholar 

  34. López-Sendón J, Coma-Canella I, Alcasena M, Seoane J, Gamallo C. Electrocardiographic findings in acute right ventricular infarction. Sensitivity and specificity of electrocardiographic alterations in leads V4R, V3R, V1, V2, V3. J Am Coll Cardiol 1985;6:1273–1285.

    Article  PubMed  Google Scholar 

  35. López-Sendón J, GarcÍa Fernandez MA, Coma-Canella I, Moreno Yangüela M, Bañuelos F. Segmental right ventricular function after acute myocardial infarction: Two-dimensional echocardiographic study in 63 patients. Am J Cardiol 1983;51:390–396.

    Article  PubMed  Google Scholar 

  36. López-Sendón J, Coma-Canella I, Gonzalez Maqueda I, Martín Jadraque L. Inverted interatrial septum convexity. A new echocardiographic alteration after right ventricular infarction. J Am Coll Cardiol 1990;15;801–805.

    PubMed  Google Scholar 

  37. Zehender M, Kasper W, Kauder E, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 1993;328:981–988.

    Article  CAS  PubMed  Google Scholar 

  38. López-Sendón J, Coma-Canella I, Viñuelas Adanez J. Volume loading in patients with ischemic right ventricular dysfunction. Eur Heart J 1981;2:329–338.

    PubMed  Google Scholar 

  39. López-Sendón J, López de Sá E, Delcán JL. Ischemic right ventricular dysfunction. Cardiovasc Drugs and Therap 1994;8:393–406.

    Article  Google Scholar 

  40. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction: etiologies, management and outcome: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000;36:1063–1070.

    Article  CAS  PubMed  Google Scholar 

  41. Adams DH, Filsoufi F, Aklog L. Surgical treatment of the ischemic mitral valve. J Heart Valve Dis 2002;11:S21–S25.

    PubMed  Google Scholar 

  42. López-Sendón J, Gonzalez A, Coma-Canella I, et al. Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria. J Am Coll Cardiol 1992;19:1145–1153.

    Article  PubMed  Google Scholar 

  43. López-Sendón J, López de Sá E, GarcÍa Fernandez MA, Moreno Yangüela M. Echocardiographic assessment of myocardial rupture to direct a successful repair. Cor Art Dis 1996;7:217–223.

    Google Scholar 

  44. Granger CB, Steg PG, Peterson E, et al., for the GRACE Investigators. Medication performance measures and mortality following acute coronary syndromes Am J Med 2005;118:858–865.

    Article  PubMed  Google Scholar 

  45. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115–1140.

    Article  PubMed  CAS  Google Scholar 

  46. López-Sendón J, Swedberg K, McMurray J, et al. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 2004;25:1454–1470.

    Article  PubMed  Google Scholar 

  47. López-Sendón J, Swedberg K, McMurray J, et al. Expert consensus document on beta-adrenergic receptor blockers. The task Force on ACEinhibitors of the European Society of Cardiology. European Society of Cardiology consensus statement. Eur Heart J 2004;25:1341–1362.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cariology, Hospital Universitario La Paz, Madrid, Spain

    José López-Sendón MD, PhD

  2. Coronary Care Unit, Hospital Universitario La Paz, Madrid, Spain

    Esteban López de Sá

Authors
  1. José López-Sendón MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Esteban López de Sá
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Anesthesiology and Critical Care Medicine, Lariboisière University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Paris, France

    Alexandre Mebazaa MD, PhD (Professor of Medicine) (Professor of Medicine)

  2. Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

    Mihai Gheorghiade MD, FACC (Professor of Medicine and Surgery, Associate Chief, Division of Cardiology and Chief, Cardiology Clinical Service) (Professor of Medicine and Surgery, Associate Chief, Division of Cardiology and Chief, Cardiology Clinical Service)

  3. Department of Cardiology Centre d’Investigation Clinique (CIC), INSERM U-684, Centre Hospitalier Universitaire, University Henri Poincaré, Nancy, France

    Faiez M. Zannad MD, PhD, FESC (Professor of Medicine) (Professor of Medicine)

  4. Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Camden, NJ, USA

    Joseph E. Parrillo MD (Professor of Medicine, Chief, Department of Medicine Edward D. Viner MD Chair, Department of Medicine and Director) (Professor of Medicine, Chief, Department of Medicine Edward D. Viner MD Chair, Department of Medicine and Director)

  5. Cooper Heart Institute, Cooper University Hospital, Camden, NJ, USA

    Joseph E. Parrillo MD (Professor of Medicine, Chief, Department of Medicine Edward D. Viner MD Chair, Department of Medicine and Director) (Professor of Medicine, Chief, Department of Medicine Edward D. Viner MD Chair, Department of Medicine and Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

López-Sendón, J., López de Sá, E. (2008). Acute Heart Failure in the Setting of Acute Coronary Syndromes. In: Mebazaa, A., Gheorghiade, M., Zannad, F.M., Parrillo, J.E. (eds) Acute Heart Failure. Springer, London. https://doi.org/10.1007/978-1-84628-782-4_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-782-4_17

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-781-7

  • Online ISBN: 978-1-84628-782-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation